ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Malignancy and tumor necrosis factor (TNF)"

  • Abstract Number: 1226 • ACR/ARHP Annual Meeting 2015

    Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration

    Yesim Ozguler1, Yusuf Yazici2, Gulen Hatemi1 and Hasan Yazici3, 1Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey

    Background/Purpose: Whether anti- TNF agents increase the frequency of neoplasms remains debated.  The drug regulatory agencies still mandate black boxes on the related package inserts…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology